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Abstract
The filamentous fungi, owing to their ability to secrete high levels of proteins, are attractive organisms for
the expression and secretion of heterologous proteins of commercial and medical value. We report the
construction of three expression vectors for the production of heterologous proteins in Neurospora
crassa and demonstrate their utility by expression of a bovine preprochymosin cDNA and secretion of
processed, enzymatically active bovine chymosin.
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Expression vectors for Neurospora crassa and
expression of a bovine preprochymosin cDNA
Eileen T. Nakano, Raymond D. Fox, David E. Clements, Ken Koo, W. Dorsey Stuart*, and John
M. Ivy - Hawaii Biotechnology Group, Inc., Aiea, HI 96701 and *Department of Genetics,
University of Hawaii (present addresses: R.D.F. Icos, Bothel WA, 98201; K.K. Hitachi Chemical
Research Center, Irvine, CA 92715)
The filamentous fungi, owing to their ability to secrete high levels of proteins, are attractive
organisms for the expression and secretion of heterologous proteins of commercial and medical
value. We report the construction of three expression vectors for the production of heterologous
proteins in Neurospora crassa and demonstrate their utility by expression of a bovine
preprochymosin cDNA and secretion of processed, enzymatically active bovine chymosin. One
of the three vectors is based on the constitutive transcriptional promoter and terminator of the
beta-tubulin gene (Orbach et al. 1988. Mol. Cell. Biol. 8:2111-2118), and the other two
incorporate the glucose repressible promoter and the terminator of grg-1 (McNally and Free
1989. Curr. Genet. 14:545-551). Results on the different levels of chymosin expression are
presented.
The beta-tubulin promoter vector, pTPT1, was constructed in pTZ18R (Pharmacia), in which
several of the multiple cloning sites were deleted. The beta-tubulin promoter and terminator
fragments were subcloned from pSV50 (Vollmer and Yanofsky 1986. Proc. Natl. Acad. Sci.
USA 83:4869-4873), which expresses a mutant, benomyl resistant beta-tubulin allele. A 350
base pair SalI-SfaNI promoter fragment, ending five nucleotides upstream of the translation
initiating ATG, and a 380 bp beta-tubulin terminator fragment, from an ExoIII-generated end 73
nucleotides upstream of the beta-tubulin stop codon to the downstream genomic HindIII site,
were combined with KpnI, SmaI and BamHI sites between them.
The two grg-1 promoter vectors are based on a genomic clone of grg-1 into which an XhoI linker
had been inserted (pMTF52, gift of S. Free, State University of New York at Buffalo) 67
nucleotides downstream of the primary site of transcriptional initiation (22 nucleotides upstream
of the first ATG codon). A second XhoI linker was inserted into an NaeI site downstream of the
last grg-1 exon and upstream of the polyadenylation signal, and all sequences between the two
XhoI sites were deleted. One version of the grg-1 promoter expression vector, pGRGS, has an
837 bp promoter fragment measured from the first site of transcription initiation, and the other,
pGRGL, has a 1563 bp promoter fragment.
A bovine preprochymosin cDNA (pBC8, gift of M. McCaman, Berlex) was subcloned into the
three expression vectors and pMTF52. After initially subcloning the cDNA into pTZ18R, the
cDNA was inserted into pTPT1 between the KpnI and BamHI sites and into pGRGS, pGRGL,
and pMTF52 at the unique XhoI site generating pTCT1, pGRGSC, pGRGLC and pGRC52
(Figure 1), respectively. Chymosin, an aspartyl protease, is secreted as a zymogen, prochymosin,
which is autocatalytically activated to chymosin at low pH. The enzyme is naturally found in the
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fourth stomach of the calf and cleaves kappa-casein. We took advantage of this milk clotting
activity to rapidly screen transformants for expression and secretion of chymosin.

Figure 1. Neurospora crassa expression vectors TCT1, pGRGSC, and pGRGLC. Steps in the
construction of the chymosin expression plasmids are described in the text. Presented are the
expression cassettes for each plasmid. Stippled boxes represent the respective promoter and
terminator sequences (beta-tubulin or grg-1). Open arrow represents preprochymosin sequences.
We co-transformed the his-2 mtr strain of N. crassa (Stuart and Koo 1988. Genome 30:198-203)
with either pTCT1, pGRGSC, pGRGLC, or pGRC52 and pSV50- cosmid 6:11E, bearing his-2+,
from the ordered cosmid library of Vollmer and Yanofsky (ibid). Histidine prototrophs were
selected on minimal medium, and transformants were transferred to agar slants. Conidia from
isolated transformants were inoculated into 5 ml of Vogel's + 2% sucrose liquid medium.
Following three to four days incubation, the medium was screened for presence of milk clotting
activity (Ward et al. 1990. Bio/Techniques 8:436-440).
Quantitation of chymosin levels from selected transformants was determined by comparison of
bovine chymosin (Sigma) and recombinant chymosin on Western transfers (Figure 2). Secreted
proteins from four-to-five-day-old cultures were concentrated by ultrafiltration (Centricon 30,
Amicon), and Western transfers were probed with a rabbit anti-prochymosin antiserum (gift of
M. McCaman, Berlex). An immunoreactive protein comigrating with bovine chymosin was
observed in the culture medium of most milk- clotting transformants (Fig. 2). In some instances,
a higher molecular weight, immunoreactive protein was observed (e.g. see Fig. 2A, lanes 3 and
4) that might represent prochymosin or pseudochymosin.
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Figure 2. Western transfer of medium from various N. crassa transformants. A. Lane 1.
Molecular weight markers. Phosphorylase B, 106 kD; Bovine serum albumin 80 kD; Ovalbumin
49.5 kD; Carbonic anhydrase 32.5 kD; Soybean trypsin inhibitor 27.5 kD; Lysozyme 18.5 kD.
Lane 2. 100 ng authentic bovine chymosin standard. Lane 3. Concentrated medium (equivalent
to 210 l of unconcentrated medium) from a pTCT1 transformant. B. Lanes 1-5: authentic bovine
chymosin standards, 100 ng, 33.3 ng, 11.1 ng, 3.7 ng, 1.2 ng, respectively. Lanes 6-13: 12 l
medium from individual transformants. Lanes 6-10: pGRGSC transformants. Lanes 11-13:
pGRGLC transformants. (arrow) - mature chymosin
A range of secreted chymosin levels as assessed by milk clotting activity was observed among
the various sets of transformants. As determined by Western transfer analysis for the highest
expressors from each set, the non-regulated beta-tubulin promoter vector and pGRGS expressed
approximately the same level of chymosin, while the longer grg-1 promoter vector, pGRGL,
produced more. We estimated that the highest expressing pTCT1 transformant expresses
between 0.3-0.5 ug/ml of enzymatically active chymosin. The highest expressing pGRGLC
transformant secretes between 0.9-1.2 ug/ml enzymatically active recombinant bovine chymosin.
The authenticity of the N. crassa-expressed chymosin was evaluated by immunoprecipitation.
The anti-prochymosin serum was added to 1 ml of culture medium from a five day culture of a
chymosin transformant, the mixture was incubated overnight at 4 C, and fixed Staphylococcus
aureus cells were added to remove the antibody-antigen complexes. This treatment removed
essentially all milk clotting activity. In addition, milk clotting was not inhibited by the serine
protease inhibitor phenylmethysulfonyl fluoride.
Summary: We have constructed three expression vectors based on the constitutive beta-tubulin
promoter and the regulatable grg-1 promoter. We have confirmed the effectiveness of these
vectors by the expression and secretion of the enzymatically active mammalian protein bovine
chymosin. The chymosin was expressed from a bovine preprochymosin cDNA, and chymosin
was secreted under the direction of its own secretion signal. Very little chymosin was detected in
cellular protein extracts, indicating the efficiency of this heterologous secretion signal peptide in
Neurospora. This is in contrast to its poor effectiveness in directing secretion of chymosin from
Saccharomyces cerevisiae (Smith et al. 1985. Science 229:1219-1224) and Aspergillus (Ward et
al. 1990. Bio/Techniques 8:436-440). However, secretion signal efficiency is highly variable and
often appears to be protein specific. We might therefore expect a homologous fungal secretion
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signal sequence to direct secretion of some proteins better than a heterologous secretion signal
sequence. To that end, we are cloning cDNAs of selected Neurospora proteins.
These expression vectors may be useful for the overexpression and study of homologous proteins
and for the expression of heterologous proteins in N. crassa. Neurospora crassa naturally
secretes few proteins, which may simplify purification of heterologous proteins targeted for
secretion and engineered for overexpression. Neurospora crassa, therefore, has potential for
development as a safe and well understood production organism.
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